Skip to main content
Top
Published in: BMC Cancer 1/2005

Open Access 01-12-2005 | Research article

Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro

Authors: Anna C Gustafsson, Ilya Kupershmidt, Esther Edlundh-Rose, Giulia Greco, Annalucia Serafino, Eva K Krasnowska, Thomas Lundeberg, Luisa Bracci-Laudiero, Maria-Concetta Romano, Tiziana Parasassi, Joakim Lundeberg

Published in: BMC Cancer | Issue 1/2005

Login to get access

Abstract

Background

Cancer prevention trials using different types of antioxidant supplements have been carried out at several occasions and one of the investigated compounds has been the antioxidant N-acetyl-L-cysteine (NAC). Studies at the cellular level have previously demonstrated that a single supplementation of NAC induces a ten-fold more rapid differentiation in normal primary human keratinocytes as well as a reversion of a colon carcinoma cell line from neoplastic proliferation to apical-basolateral differentiation [1]. The investigated cells showed an early change in the organization of the cytoskeleton, several newly established adherens junctions with E-cadherin/β-catenin complexes and increased focal adhesions, all features characterizing the differentiation process.

Methods

In order to investigate the molecular mechanisms underlying the proliferation arrest and accelerated differentiation induced by NAC treatment of NHEK and Caco-2 cells in vitro, we performed global gene expression analysis of NAC treated cells in a time series (1, 12 and 24 hours post NAC treatment) using the Affymetrix GeneChip™ Human Genome U95Av2 chip, which contains approximately 12,000 previously characterized sequences. The treated samples were compared to the corresponding untreated culture at the same time point.

Results

Microarray data analysis revealed an increasing number of differentially expressed transcripts over time upon NAC treatment. The early response (1 hour) was transient, while a constitutive trend was commonly found among genes differentially regulated at later time points (12 and 24 hours). Connections to the induction of differentiation and inhibition of growth were identified for a majority of up- and down-regulated genes. All of the observed transcriptional changes, except for seven genes, were unique to either cell line. Only one gene, ID-1, was mutually regulated at 1 hour post treatment and might represent a common mediator of early NAC action.
The detection of several genes that previously have been identified as stimulated or repressed during the differentiation of NHEK and Caco-2 provided validation of results. In addition, real-time kinetic PCR analysis of selected genes also verified the differential regulation as identified by the microarray platform.

Conclusion

NAC induces a limited and transient early response followed by a more consistent and extensively different expression at later time points in both the normal and cancer cell lines investigated. The responses are largely related to inhibition of proliferation and stimulation of differentiation in both cell types but are almost completely lineage specific. ID-1 is indicated as an early mediator of NAC action.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parasassi T, Brunelli R, Bracci-Laudiero L, Greco G, Gustafsson AC, Krasnowska EK, Lundeberg J, Lundeberg T, Pittaluga E, Romano MC, Serafino A: Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms. Cell Death Differ. 2005 Parasassi T, Brunelli R, Bracci-Laudiero L, Greco G, Gustafsson AC, Krasnowska EK, Lundeberg J, Lundeberg T, Pittaluga E, Romano MC, Serafino A: Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms. Cell Death Differ. 2005
2.
go back to reference Delie F, Rubas W: A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst. 1997, 14: 221-286.CrossRefPubMed Delie F, Rubas W: A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst. 1997, 14: 221-286.CrossRefPubMed
3.
go back to reference Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol. 2003, 4: R70-10.1186/gb-2003-4-10-r70.CrossRefPubMedPubMedCentral Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol. 2003, 4: R70-10.1186/gb-2003-4-10-r70.CrossRefPubMedPubMedCentral
4.
go back to reference De Flora S, Izzotti A, D'Agostini F, Balansky RM: Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis. 2001, 22: 999-1013. 10.1093/carcin/22.7.999.CrossRefPubMed De Flora S, Izzotti A, D'Agostini F, Balansky RM: Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis. 2001, 22: 999-1013. 10.1093/carcin/22.7.999.CrossRefPubMed
5.
go back to reference Rosati E, Sabatini R, Ayroldi E, Tabilio A, Bartoli A, Bruscoli S, Simoncelli C, Rossi R, Marconi P: Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine. J Leukoc Biol. 2004, 76: 152-161. 10.1189/jlb.0403148.CrossRefPubMed Rosati E, Sabatini R, Ayroldi E, Tabilio A, Bartoli A, Bruscoli S, Simoncelli C, Rossi R, Marconi P: Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine. J Leukoc Biol. 2004, 76: 152-161. 10.1189/jlb.0403148.CrossRefPubMed
6.
go back to reference Hart AM, Terenghi G, Kellerth JO, Wiberg M: Sensory neuroprotection, mitochondrial preservation, and therapeutic potential of n-acetyl-cysteine after nerve injury. Neuroscience. 2004, 125: 91-101. 10.1016/j.neuroscience.2003.12.040.CrossRefPubMed Hart AM, Terenghi G, Kellerth JO, Wiberg M: Sensory neuroprotection, mitochondrial preservation, and therapeutic potential of n-acetyl-cysteine after nerve injury. Neuroscience. 2004, 125: 91-101. 10.1016/j.neuroscience.2003.12.040.CrossRefPubMed
7.
go back to reference Rhoden CR, Lawrence J, Godleski JJ, Gonzalez-Flecha B: N-acetylcysteine prevents lung inflammation after short-term inhalation exposure to concentrated ambient particles. Toxicol Sci. 2004, 79: 296-303. 10.1093/toxsci/kfh122.CrossRefPubMed Rhoden CR, Lawrence J, Godleski JJ, Gonzalez-Flecha B: N-acetylcysteine prevents lung inflammation after short-term inhalation exposure to concentrated ambient particles. Toxicol Sci. 2004, 79: 296-303. 10.1093/toxsci/kfh122.CrossRefPubMed
8.
go back to reference Estensen RD, Levy M, Klopp SJ, Galbraith AR, Mandel JS, Blomquist JA, Wattenberg LW: N-acetylcysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps. Cancer Lett. 1999, 147: 109-114. 10.1016/S0304-3835(99)00281-5.CrossRefPubMed Estensen RD, Levy M, Klopp SJ, Galbraith AR, Mandel JS, Blomquist JA, Wattenberg LW: N-acetylcysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps. Cancer Lett. 1999, 147: 109-114. 10.1016/S0304-3835(99)00281-5.CrossRefPubMed
9.
go back to reference Tadjali M, Seidelin JB, Olsen J, Troelsen JT: Transcriptome changes during intestinal cell differentiation. Biochim Biophys Acta. 2002, 1589: 160-167. 10.1016/S0167-4889(02)00170-2.CrossRefPubMed Tadjali M, Seidelin JB, Olsen J, Troelsen JT: Transcriptome changes during intestinal cell differentiation. Biochim Biophys Acta. 2002, 1589: 160-167. 10.1016/S0167-4889(02)00170-2.CrossRefPubMed
10.
go back to reference Mariadason JM, Arango D, Corner GA, Aranes MJ, Hotchkiss KA, Yang W, Augenlicht LH: A gene expression profile that defines colon cell maturation in vitro. Cancer Res. 2002, 62: 4791-4804.PubMed Mariadason JM, Arango D, Corner GA, Aranes MJ, Hotchkiss KA, Yang W, Augenlicht LH: A gene expression profile that defines colon cell maturation in vitro. Cancer Res. 2002, 62: 4791-4804.PubMed
11.
go back to reference Fleet JC, Wang L, Vitek O, Craig BA, Edenberg HJ: Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation. Physiol Genomics. 2003, 13: 57-68.CrossRefPubMed Fleet JC, Wang L, Vitek O, Craig BA, Edenberg HJ: Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation. Physiol Genomics. 2003, 13: 57-68.CrossRefPubMed
12.
go back to reference Sun XH, Copeland NG, Jenkins NA, Baltimore D: Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol. 1991, 11: 5603-5611.CrossRefPubMedPubMedCentral Sun XH, Copeland NG, Jenkins NA, Baltimore D: Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol. 1991, 11: 5603-5611.CrossRefPubMedPubMedCentral
13.
go back to reference Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K: Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem. 1994, 269: 2139-2145.PubMed Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K: Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem. 1994, 269: 2139-2145.PubMed
14.
go back to reference Sun XH: Constitutive expression of the Id1 gene impairs mouse B cell development. Cell. 1994, 79: 893-900. 10.1016/0092-8674(94)90078-7.CrossRefPubMed Sun XH: Constitutive expression of the Id1 gene impairs mouse B cell development. Cell. 1994, 79: 893-900. 10.1016/0092-8674(94)90078-7.CrossRefPubMed
15.
go back to reference Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E: Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 2001, 409: 1067-1070. 10.1038/35059131.CrossRefPubMed Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E: Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 2001, 409: 1067-1070. 10.1038/35059131.CrossRefPubMed
16.
go back to reference Bjorntorp E, Parsa R, Thornemo M, Wennberg AM, Lindahl A: The helix-loop-helix transcription factor Id1 is highly expressed in psoriatic involved skin. Acta Derm Venereol. 2003, 83: 403-409. 10.1080/00015550310015806.CrossRefPubMed Bjorntorp E, Parsa R, Thornemo M, Wennberg AM, Lindahl A: The helix-loop-helix transcription factor Id1 is highly expressed in psoriatic involved skin. Acta Derm Venereol. 2003, 83: 403-409. 10.1080/00015550310015806.CrossRefPubMed
17.
go back to reference Strait KA, Dabbas B, Hammond EH, Warnick CT, Iistrup SJ, Ford CD: Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. Mol Cancer Ther. 2002, 1: 1181-1190.PubMed Strait KA, Dabbas B, Hammond EH, Warnick CT, Iistrup SJ, Ford CD: Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. Mol Cancer Ther. 2002, 1: 1181-1190.PubMed
18.
go back to reference Ezura Y, Tournay O, Nifuji A, Noda M: Identification of a novel suppressive vitamin D response sequence in the 5'-flanking region of the murine Id1 gene. J Biol Chem. 1997, 272: 29865-29872. 10.1074/jbc.272.47.29865.CrossRefPubMed Ezura Y, Tournay O, Nifuji A, Noda M: Identification of a novel suppressive vitamin D response sequence in the 5'-flanking region of the murine Id1 gene. J Biol Chem. 1997, 272: 29865-29872. 10.1074/jbc.272.47.29865.CrossRefPubMed
19.
go back to reference Tournay O, Benezra R: Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol Cell Biol. 1996, 16: 2418-2430.CrossRefPubMedPubMedCentral Tournay O, Benezra R: Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol Cell Biol. 1996, 16: 2418-2430.CrossRefPubMedPubMedCentral
20.
go back to reference Liu C, Yao J, de Belle I, Huang RP, Adamson E, Mercola D: The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem. 1999, 274: 4400-4411. 10.1074/jbc.274.7.4400.CrossRefPubMed Liu C, Yao J, de Belle I, Huang RP, Adamson E, Mercola D: The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem. 1999, 274: 4400-4411. 10.1074/jbc.274.7.4400.CrossRefPubMed
21.
go back to reference Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, McKeon F, Haber DA: REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell. 2002, 10: 995-1005. 10.1016/S1097-2765(02)00706-2.CrossRefPubMed Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, McKeon F, Haber DA: REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell. 2002, 10: 995-1005. 10.1016/S1097-2765(02)00706-2.CrossRefPubMed
22.
go back to reference Suminami Y, Nagashima S, Murakami A, Nawata S, Gondo T, Hirakawa H, Numa F, Silverman GA, Kato H: Suppression of a squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells. Cancer Res. 2001, 61: 1776-1780.PubMed Suminami Y, Nagashima S, Murakami A, Nawata S, Gondo T, Hirakawa H, Numa F, Silverman GA, Kato H: Suppression of a squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells. Cancer Res. 2001, 61: 1776-1780.PubMed
23.
go back to reference Chen Y, Riley DJ, Chen PL, Lee WH: HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis. Mol Cell Biol. 1997, 17: 6049-6056.CrossRefPubMedPubMedCentral Chen Y, Riley DJ, Chen PL, Lee WH: HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis. Mol Cell Biol. 1997, 17: 6049-6056.CrossRefPubMedPubMedCentral
24.
go back to reference Semprini S, Capon F, Tacconelli A, Giardina E, Orecchia A, Mingarelli R, Gobello T, Zambruno G, Botta A, Fabrizi G, Novelli G: Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees. Hum Genet. 2002, 111: 310-313. 10.1007/s00439-002-0812-5.CrossRefPubMed Semprini S, Capon F, Tacconelli A, Giardina E, Orecchia A, Mingarelli R, Gobello T, Zambruno G, Botta A, Fabrizi G, Novelli G: Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees. Hum Genet. 2002, 111: 310-313. 10.1007/s00439-002-0812-5.CrossRefPubMed
25.
go back to reference Yousef GM, Diamandis EP: Tissue kallikreins: new players in normal and abnormal cell growth?. Thromb Haemost. 2003, 90: 7-16.PubMed Yousef GM, Diamandis EP: Tissue kallikreins: new players in normal and abnormal cell growth?. Thromb Haemost. 2003, 90: 7-16.PubMed
26.
go back to reference Talieri M, Diamandis EP, Gourgiotis D, Mathioudaki K, Scorilas A: Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb Haemost. 2004, 91: 180-186.PubMed Talieri M, Diamandis EP, Gourgiotis D, Mathioudaki K, Scorilas A: Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb Haemost. 2004, 91: 180-186.PubMed
27.
go back to reference McGowan CH, Russell P: Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. Embo J. 1993, 12: 75-85.PubMedPubMedCentral McGowan CH, Russell P: Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. Embo J. 1993, 12: 75-85.PubMedPubMedCentral
28.
go back to reference Sonoyama K, Rutatip S, Kasai T: Gene expression of activin, activin receptors, and follistatin in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2000, 278: G89-97.PubMed Sonoyama K, Rutatip S, Kasai T: Gene expression of activin, activin receptors, and follistatin in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2000, 278: G89-97.PubMed
29.
go back to reference Chen YG, Lui HM, Lin SL, Lee JM, Ying SY: Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood). 2002, 227: 75-87. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY: Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood). 2002, 227: 75-87.
30.
go back to reference Murata M, Eto Y, Shibai H, Sakai M, Muramatsu M: Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin beta A chain. Proc Natl Acad Sci U S A. 1988, 85: 2434-2438.CrossRefPubMedPubMedCentral Murata M, Eto Y, Shibai H, Sakai M, Muramatsu M: Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin beta A chain. Proc Natl Acad Sci U S A. 1988, 85: 2434-2438.CrossRefPubMedPubMedCentral
31.
go back to reference Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, et al: The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res. 2002, 62: 5273-5279.PubMed Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, et al: The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res. 2002, 62: 5273-5279.PubMed
32.
go back to reference Horuk R, Yansura DG, Reilly D, Spencer S, Bourell J, Henzel W, Rice G, Unemori E: Purification, receptor binding analysis, and biological characterization of human melanoma growth stimulating activity (MGSA). Evidence for a novel MGSA receptor. J Biol Chem. 1993, 268: 541-546.PubMed Horuk R, Yansura DG, Reilly D, Spencer S, Bourell J, Henzel W, Rice G, Unemori E: Purification, receptor binding analysis, and biological characterization of human melanoma growth stimulating activity (MGSA). Evidence for a novel MGSA receptor. J Biol Chem. 1993, 268: 541-546.PubMed
33.
go back to reference Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, et al: Identification of heregulin, a specific activator of p185erbB2. Science. 1992, 256: 1205-1210.CrossRefPubMed Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, et al: Identification of heregulin, a specific activator of p185erbB2. Science. 1992, 256: 1205-1210.CrossRefPubMed
34.
go back to reference Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR, Williams RS: Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci U S A. 1998, 95: 3603-3608. 10.1073/pnas.95.7.3603.CrossRefPubMedPubMedCentral Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR, Williams RS: Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci U S A. 1998, 95: 3603-3608. 10.1073/pnas.95.7.3603.CrossRefPubMedPubMedCentral
35.
go back to reference Grdina DJ, Murley JS, Roberts JC: Effects of thiols on topoisomerase-II alpha activity and cell cycle progression. Cell Prolif. 1998, 31: 217-229.CrossRefPubMed Grdina DJ, Murley JS, Roberts JC: Effects of thiols on topoisomerase-II alpha activity and cell cycle progression. Cell Prolif. 1998, 31: 217-229.CrossRefPubMed
36.
go back to reference Mondal N, Parvin JD: DNA topoisomerase IIalpha is required for RNA polymerase II transcription on chromatin templates. Nature. 2001, 413: 435-438. 10.1038/35096590.CrossRefPubMed Mondal N, Parvin JD: DNA topoisomerase IIalpha is required for RNA polymerase II transcription on chromatin templates. Nature. 2001, 413: 435-438. 10.1038/35096590.CrossRefPubMed
37.
go back to reference Fesus L, Piacentini M: Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci. 2002, 27: 534-539. 10.1016/S0968-0004(02)02182-5.CrossRefPubMed Fesus L, Piacentini M: Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci. 2002, 27: 534-539. 10.1016/S0968-0004(02)02182-5.CrossRefPubMed
38.
go back to reference Mishra S, Murphy LJ: Tissue transglutaminase has intrinsic kinase activity: Identification of transglutaminase 2 as an insulin-like growth factor binding protein-3 kinase. J Biol Chem. 2004, 279 (23): 23863-8. 10.1074/jbc.M311919200.CrossRefPubMed Mishra S, Murphy LJ: Tissue transglutaminase has intrinsic kinase activity: Identification of transglutaminase 2 as an insulin-like growth factor binding protein-3 kinase. J Biol Chem. 2004, 279 (23): 23863-8. 10.1074/jbc.M311919200.CrossRefPubMed
39.
go back to reference Ricort JM, Binoux M: Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. J Biol Chem. 2002, 277: 19448-19454. 10.1074/jbc.M200439200.CrossRefPubMed Ricort JM, Binoux M: Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. J Biol Chem. 2002, 277: 19448-19454. 10.1074/jbc.M200439200.CrossRefPubMed
40.
41.
go back to reference Ray JM, Stetler-Stevenson WG: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J. 1994, 7: 2062-2072.PubMed Ray JM, Stetler-Stevenson WG: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J. 1994, 7: 2062-2072.PubMed
42.
go back to reference Coussens LM, Werb Z: Matrix metalloproteinases and the development of cancer. Chem Biol. 1996, 3: 895-904. 10.1016/S1074-5521(96)90178-7.CrossRefPubMed Coussens LM, Werb Z: Matrix metalloproteinases and the development of cancer. Chem Biol. 1996, 3: 895-904. 10.1016/S1074-5521(96)90178-7.CrossRefPubMed
43.
go back to reference Cai T, Fassina G, Morini M, Aluigi MG, Masiello L, Fontanini G, D'Agostini F, De Flora S, Noonan DM, Albini A: N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest. 1999, 79: 1151-1159.PubMed Cai T, Fassina G, Morini M, Aluigi MG, Masiello L, Fontanini G, D'Agostini F, De Flora S, Noonan DM, Albini A: N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest. 1999, 79: 1151-1159.PubMed
44.
go back to reference Mashimo H, Wu DC, Podolsky DK, Fishman MC: Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996, 274: 262-265. 10.1126/science.274.5285.262.CrossRefPubMed Mashimo H, Wu DC, Podolsky DK, Fishman MC: Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996, 274: 262-265. 10.1126/science.274.5285.262.CrossRefPubMed
45.
go back to reference Agre P, Brown D, Nielsen S: Aquaporin water channels: unanswered questions and unresolved controversies. Curr Opin Cell Biol. 1995, 7: 472-483. 10.1016/0955-0674(95)80003-4.CrossRefPubMed Agre P, Brown D, Nielsen S: Aquaporin water channels: unanswered questions and unresolved controversies. Curr Opin Cell Biol. 1995, 7: 472-483. 10.1016/0955-0674(95)80003-4.CrossRefPubMed
46.
go back to reference Delporte C, Chen ZJ, Baum BJ: Aquaporin 1 expression during the cell cycle in A5 cells. Biochem Biophys Res Commun. 1996, 228: 223-228. 10.1006/bbrc.1996.1645.CrossRefPubMed Delporte C, Chen ZJ, Baum BJ: Aquaporin 1 expression during the cell cycle in A5 cells. Biochem Biophys Res Commun. 1996, 228: 223-228. 10.1006/bbrc.1996.1645.CrossRefPubMed
47.
go back to reference Matsuzaki T, Suzuki T, Koyama H, Tanaka S, Takata K: Water channel protein AQP3 is present in epithelia exposed to the environment of possible water loss. J Histochem Cytochem. 1999, 47: 1275-1286.CrossRefPubMed Matsuzaki T, Suzuki T, Koyama H, Tanaka S, Takata K: Water channel protein AQP3 is present in epithelia exposed to the environment of possible water loss. J Histochem Cytochem. 1999, 47: 1275-1286.CrossRefPubMed
48.
go back to reference Koyama Y, Yamamoto T, Tani T, Nihei K, Kondo D, Funaki H, Yaoita E, Kawasaki K, Sato N, Hatakeyama K, Kihara I: Expression and localization of aquaporins in rat gastrointestinal tract. Am J Physiol. 1999, 276: C621-627.PubMed Koyama Y, Yamamoto T, Tani T, Nihei K, Kondo D, Funaki H, Yaoita E, Kawasaki K, Sato N, Hatakeyama K, Kihara I: Expression and localization of aquaporins in rat gastrointestinal tract. Am J Physiol. 1999, 276: C621-627.PubMed
49.
go back to reference Zheng X, Bollinger Bollag W: Aquaporin 3 colocates with phospholipase d2 in caveolin-rich membrane microdomains and is downregulated upon keratinocyte differentiation. J Invest Dermatol. 2003, 121: 1487-1495. 10.1111/j.1523-1747.2003.12614.x.CrossRefPubMed Zheng X, Bollinger Bollag W: Aquaporin 3 colocates with phospholipase d2 in caveolin-rich membrane microdomains and is downregulated upon keratinocyte differentiation. J Invest Dermatol. 2003, 121: 1487-1495. 10.1111/j.1523-1747.2003.12614.x.CrossRefPubMed
50.
go back to reference Heinen CD, Goss KH, Cornelius JR, Babcock GF, Knudsen ES, Kowalik T, Groden J: The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway. Gastroenterology. 2002, 123: 751-763. 10.1053/gast.2002.35382.CrossRefPubMed Heinen CD, Goss KH, Cornelius JR, Babcock GF, Knudsen ES, Kowalik T, Groden J: The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway. Gastroenterology. 2002, 123: 751-763. 10.1053/gast.2002.35382.CrossRefPubMed
51.
go back to reference Wei Y, Renard CA, Labalette C, Wu Y, Levy L, Neuveut C, Prieur X, Flajolet M, Prigent S, Buendia MA: Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J Biol Chem. 2003, 278: 5188-5194. 10.1074/jbc.M207216200.CrossRefPubMed Wei Y, Renard CA, Labalette C, Wu Y, Levy L, Neuveut C, Prieur X, Flajolet M, Prigent S, Buendia MA: Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J Biol Chem. 2003, 278: 5188-5194. 10.1074/jbc.M207216200.CrossRefPubMed
52.
go back to reference Bernard DJ, Chapman SC, Woodruff TK: Mechanisms of inhibin signal transduction. Recent Prog Horm Res. 2001, 56: 417-450. 10.1210/rp.56.1.417.CrossRefPubMed Bernard DJ, Chapman SC, Woodruff TK: Mechanisms of inhibin signal transduction. Recent Prog Horm Res. 2001, 56: 417-450. 10.1210/rp.56.1.417.CrossRefPubMed
53.
go back to reference Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ, Olson JM: BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med. 2003, 9: 1033-1038. 10.1038/nm904.CrossRefPubMed Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ, Olson JM: BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med. 2003, 9: 1033-1038. 10.1038/nm904.CrossRefPubMed
54.
go back to reference Wen XZ, Miyake S, Akiyama Y, Yuasa Y: BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. Biochem Biophys Res Commun. 2004, 316: 100-106. 10.1016/j.bbrc.2004.02.016.CrossRefPubMed Wen XZ, Miyake S, Akiyama Y, Yuasa Y: BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. Biochem Biophys Res Commun. 2004, 316: 100-106. 10.1016/j.bbrc.2004.02.016.CrossRefPubMed
55.
go back to reference Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J: The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis. 2003, 24: 1445-1454. 10.1093/carcin/bgg100.CrossRefPubMed Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J: The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis. 2003, 24: 1445-1454. 10.1093/carcin/bgg100.CrossRefPubMed
56.
go back to reference Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994, 371: 257-261. 10.1038/371257a0.CrossRefPubMed Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994, 371: 257-261. 10.1038/371257a0.CrossRefPubMed
57.
go back to reference Lee MH, Reynisdottir I, Massague J: Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 1995, 9: 639-649.CrossRefPubMed Lee MH, Reynisdottir I, Massague J: Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 1995, 9: 639-649.CrossRefPubMed
58.
go back to reference Jacobs-Helber SM, Abutin RM, Tian C, Bondurant M, Wickrema A, Sawyer ST: Role of JunB in erythroid differentiation. J Biol Chem. 2002, 277: 4859-4866. 10.1074/jbc.M107243200.CrossRefPubMed Jacobs-Helber SM, Abutin RM, Tian C, Bondurant M, Wickrema A, Sawyer ST: Role of JunB in erythroid differentiation. J Biol Chem. 2002, 277: 4859-4866. 10.1074/jbc.M107243200.CrossRefPubMed
59.
go back to reference Passegue E, Jochum W, Schorpp-Kistner M, Mohle-Steinlein U, Wagner EF: Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell. 2001, 104: 21-32. 10.1016/S0092-8674(01)00188-X.CrossRefPubMed Passegue E, Jochum W, Schorpp-Kistner M, Mohle-Steinlein U, Wagner EF: Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell. 2001, 104: 21-32. 10.1016/S0092-8674(01)00188-X.CrossRefPubMed
60.
go back to reference Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J, Magaud JP: BTG1, a member of a new family of antiproliferative genes. Embo J. 1992, 11: 1663-1670.PubMedPubMedCentral Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J, Magaud JP: BTG1, a member of a new family of antiproliferative genes. Embo J. 1992, 11: 1663-1670.PubMedPubMedCentral
61.
go back to reference Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med. 1996, 2: 776-782. 10.1038/nm0796-776.CrossRefPubMed Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med. 1996, 2: 776-782. 10.1038/nm0796-776.CrossRefPubMed
62.
go back to reference van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, Vlietstra R, Trapman J, Bosman FT: A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest. 1997, 77: 85-92.PubMed van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, Vlietstra R, Trapman J, Bosman FT: A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest. 1997, 77: 85-92.PubMed
63.
go back to reference Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM: Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice. Nat Genet. 2003, 35: 323-330. 10.1038/ng1265.CrossRefPubMed Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM: Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice. Nat Genet. 2003, 35: 323-330. 10.1038/ng1265.CrossRefPubMed
64.
go back to reference Shepherd TG, Nachtigal MW: Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology. 2003, 144: 3306-3314. 10.1210/en.2003-0185.CrossRefPubMed Shepherd TG, Nachtigal MW: Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology. 2003, 144: 3306-3314. 10.1210/en.2003-0185.CrossRefPubMed
65.
go back to reference Langenfeld EM, Langenfeld J: Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res. 2004, 2: 141-149.PubMed Langenfeld EM, Langenfeld J: Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res. 2004, 2: 141-149.PubMed
66.
go back to reference Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A. 1997, 94: 3336-3340. 10.1073/pnas.94.7.3336.CrossRefPubMedPubMedCentral Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A. 1997, 94: 3336-3340. 10.1073/pnas.94.7.3336.CrossRefPubMedPubMedCentral
67.
go back to reference Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998, 93: 705-716. 10.1016/S0092-8674(00)81433-6.CrossRefPubMed Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998, 93: 705-716. 10.1016/S0092-8674(00)81433-6.CrossRefPubMed
68.
go back to reference Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K: Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci U S A. 2001, 98: 7629-7634. 10.1073/pnas.121574098.CrossRefPubMedPubMedCentral Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K: Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci U S A. 2001, 98: 7629-7634. 10.1073/pnas.121574098.CrossRefPubMedPubMedCentral
69.
go back to reference Chinery R, Beauchamp RD, Shyr Y, Kirkland SC, Coffey RJ, Morrow JD: Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res. 1998, 58: 2323-2327.PubMed Chinery R, Beauchamp RD, Shyr Y, Kirkland SC, Coffey RJ, Morrow JD: Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res. 1998, 58: 2323-2327.PubMed
70.
go back to reference Lavender P, Vandel L, Bannister AJ, Kouzarides T: The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene. 1997, 14: 2721-2728. 10.1038/sj.onc.1201243.CrossRefPubMed Lavender P, Vandel L, Bannister AJ, Kouzarides T: The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene. 1997, 14: 2721-2728. 10.1038/sj.onc.1201243.CrossRefPubMed
71.
go back to reference Tevosian SG, Shih HH, Mendelson KG, Sheppard KA, Paulson KE, Yee AS: HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev. 1997, 11: 383-396.CrossRefPubMed Tevosian SG, Shih HH, Mendelson KG, Sheppard KA, Paulson KE, Yee AS: HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev. 1997, 11: 383-396.CrossRefPubMed
72.
go back to reference Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, Pestell RG, Paulson KE, Yee AS: Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. Embo J. 2001, 20: 4500-4511. 10.1093/emboj/20.16.4500.CrossRefPubMedPubMedCentral Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, Pestell RG, Paulson KE, Yee AS: Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. Embo J. 2001, 20: 4500-4511. 10.1093/emboj/20.16.4500.CrossRefPubMedPubMedCentral
73.
go back to reference Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science. 1997, 276: 1268-1272. 10.1126/science.276.5316.1268.CrossRefPubMed Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science. 1997, 276: 1268-1272. 10.1126/science.276.5316.1268.CrossRefPubMed
74.
go back to reference Vachon PH, Beaulieu JF: Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology. 1992, 103: 414-423.CrossRefPubMed Vachon PH, Beaulieu JF: Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology. 1992, 103: 414-423.CrossRefPubMed
75.
go back to reference Wang H, Chakrabarty S: Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells. Oncogene. 2003, 22: 2186-2191. 10.1038/sj.onc.1206348.CrossRefPubMed Wang H, Chakrabarty S: Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells. Oncogene. 2003, 22: 2186-2191. 10.1038/sj.onc.1206348.CrossRefPubMed
76.
go back to reference Shimada A, Ota Y, Sugiyama Y, Sato S, Kume K, Shimizu T, Inoue S: In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. J Invest Dermatol. 1998, 110: 889-893. 10.1046/j.1523-1747.1998.00202.x.CrossRefPubMed Shimada A, Ota Y, Sugiyama Y, Sato S, Kume K, Shimizu T, Inoue S: In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. J Invest Dermatol. 1998, 110: 889-893. 10.1046/j.1523-1747.1998.00202.x.CrossRefPubMed
Metadata
Title
Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro
Authors
Anna C Gustafsson
Ilya Kupershmidt
Esther Edlundh-Rose
Giulia Greco
Annalucia Serafino
Eva K Krasnowska
Thomas Lundeberg
Luisa Bracci-Laudiero
Maria-Concetta Romano
Tiziana Parasassi
Joakim Lundeberg
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2005
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-5-75

Other articles of this Issue 1/2005

BMC Cancer 1/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine